Potential Therapeutic Relevance of CRISPR/Cas9 Guided Epigenetic Regulations for Neuropsychiatric Disorders.

Singh, Desh D; Verma, Ravi; Parimoo, Piyush; Sahu, Ashish; Kumar, Vikram; Upadhyay, Era; Yadav, Dharmendra K

Singh, Desh D; Verma, Ravi; Parimoo, Piyush; Sahu, Ashish; Kumar, Vikram; Upadhyay, Era; Yadav, Dharmendra K.

Affiliation

Singh DD; Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, India.
Verma R; Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology (POSTECH), Pohang37673, Korea.
Parimoo P; Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, India.
Sahu A; Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, India.
Kumar V; Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, India.
Upadhyay E; Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, India.
Yadav DK; College of Pharmacy, Gachon University of Medicine and Science, Hambakmoeiro 191, Yeonsu-gu, Incheon City, Korea.

Curr Top Med Chem ; 21(10): 878-894, 2021.

Article in En | MEDLINE | ID: mdl-33739246

Subject(s)
Key words

CRISPR/Cas9; Epigenetic regulations; Gene editing; Neuronal development; Neuropsychiatric Disorders; Therapeutic applications.; Transcription factor

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neurocognitive Disorders / Epigenesis, Genetic / CRISPR-Cas Systems / Mental Disorders Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Animals / Humans Language: En Journal: Curr Top Med Chem Journal subject: QUIMICA Year: 2021 Document type: Article Affiliation country: India Country of publication: Emiratos Árabes Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google